Implementation of an Infusion Management Scheme to Improve Patient Outcome

Status Recruiting

Clinical Trial Summary

This study is a multi-center before-after trial design. The object is to observe whether the incidence of central line associated blood stream infection(CLABSI) will tend to descend compared with retrospective electronic medical record data after implementation of an infusion management scheme which comes form " Clinical Practice Guideline on Infusion Therapy in Children " .

Clinical Trial Description

Infusion therapy is an important part in pediatric ward. Most hospitalized children need indwelling vascular access devices to receive infusion therapy. Much attention has been paid to possible serious or fatal complications due to immature immune system, poor communication ability and cognitive disorder in children during catheter placement, use and maintenance. Reducing the complications related to central venous catheter has become the focus of the global health care system. Studies have shown that the technical level of operators is in connection with the incidence of CLABSI, and an intravenous infusion team (IV Team) is the key to preventing CLABSI, which may fundamentally improve the clinical outcomes of pediatric patients. From December 2021 to April 2023, taking Children's Hospital of Fudan University as the leading center, Xiamen Children's Hospital, Anhui Provincial Children's Hospital, Dalian Municipal Women and Children's Medical Group, Tongji Hospital, First Affiliated Hospital of Guangxi Medical University, Qidong Women's and Children's Health, Chengdu Women's and Children's Central Hospital, Hunan Children's Hospital as the cooperation centers. A retrospective review of electronic medical record data will be collected first. The intervention is composed of setting up a pediatric intravenous infusion team; carrying out a quality improvement in collecting and sending suspected CLABSI samples; providing infusion training curriculums to nurses in forms of lectures, group discussions, operation demonstrations, and scenario simulations, holding practice review meeting with them; providing elements to caregivers of educational leaflet, nurse-provided education during patients' infusion therapy. ;

Study Design

Related Conditions & MeSH terms

Infections

Clinical Trial Details

NCT number	NCT05152446
Study type	Interventional
Source	Children's Hospital of Fudan University
Contact	Ying Gu
Phone	8618017590969
Email	guying0128@aliyun.com
Status	Recruiting
Phase	N/A
Start date	March 7, 2022
Completion date	August 7, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06055777` - Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts	Phase 1
Recruiting	`NCT05578196` - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.	N/A
Recruiting	`NCT05793983` - S100A8/A9 and Innate Immunity in Liver Disease
Active, not recruiting	`NCT05963269` - The Effect of the Game on Students' Intramuscular Injection Skills	N/A
Not yet recruiting	`NCT06026852` - Validation of Betalactam ML Prediction Models - TDMAide	N/A
Not yet recruiting	`NCT02222779` - Quantification of Transition Metals	N/A
Completed	`NCT01976234` - Stored RBC Transfusion and Immonomodulation	N/A
Completed	`NCT01530763` - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)	Phase 2/Phase 3
Completed	`NCT02345135` - Susceptibility to Infections in Ataxia Telangiectasia	N/A
Completed	`NCT01158560` - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections	Phase 3
Completed	`NCT01176786` - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery	N/A
Active, not recruiting	`NCT05284097` - Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study	Phase 2
Enrolling by invitation	`NCT06055712` - Antibiotic Prophylaxis in Pediatric Open Fractures	Phase 4
Not yet recruiting	`NCT06402292` - Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute	N/A
Not yet recruiting	`NCT06338345` - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients	N/A
Recruiting	`NCT06002685` - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention	N/A
Completed	`NCT02802059` - E. Coli Nissle 1917 - Suspension for Infection Prophylaxis	Phase 3
Completed	`NCT05289674` - The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection	N/A
Recruiting	`NCT05770765` - Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases
Completed	`NCT05389540` - Rural South and Southeast Asia Household Health Survey

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms